Value drivers of development stage biopharma companies

Saved in:
Bibliographic Details
Main Authors: Michaeli, Daniel (Author) , Yagmur, Hasan Basri (Author) , Achmadeev, Timur (Author) , Michaeli, Christoph T. (Author)
Format: Article (Journal)
Language:English
Published: 17 January 2022
In: The European journal of health economics
Year: 2022, Volume: 23, Issue: 8, Pages: 1287-1296
ISSN:1618-7601
DOI:10.1007/s10198-021-01427-5
Subjects:
Online Access:Verlag, kostenfrei: https://link.springer.com/content/pdf/10.1007/s10198-021-01427-5.pdf
Resolving-System, kostenfrei: https://doi.org/10.1007/s10198-021-01427-5
Get full text
Author Notes:Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli

MARC

LEADER 00000caa a2200000 c 4500
001 1819636267
003 DE-627
005 20230710123413.0
007 cr uuu---uuuuu
008 221021s2022 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10198-021-01427-5  |2 doi 
035 |a (DE-627)1819636267 
035 |a (DE-599)KXP1819636267 
035 |a (OCoLC)1389536469 
035 |a (DE-He213)s10198-021-01427-5-e 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Michaeli, Daniel  |d 1997-  |e VerfasserIn  |0 (DE-588)1277183244  |0 (DE-627)1830345109  |4 aut 
245 1 0 |a Value drivers of development stage biopharma companies  |c Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli 
264 1 |c 17 January 2022 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
650 4 |a Acquisitions  |7 (dpeaa)DE-206 
650 4 |a Drug development  |7 (dpeaa)DE-206 
650 4 |a Multi-indication  |7 (dpeaa)DE-206 
650 4 |a Orphan  |7 (dpeaa)DE-206 
650 4 |a Pharmaceutical policy  |7 (dpeaa)DE-206 
650 4 |a Valuation  |7 (dpeaa)DE-206 
655 4 |0 (DE-206)49  |a Aufsatz in Zeitschrift  |5 DE-206 
700 1 |a Yagmur, Hasan Basri  |e VerfasserIn  |4 aut 
700 1 |a Achmadeev, Timur  |e VerfasserIn  |4 aut 
700 1 |a Michaeli, Christoph T.  |d 1992-  |e VerfasserIn  |0 (DE-588)1277182337  |0 (DE-627)1830343769  |4 aut 
773 0 8 |i Enthalten in  |t The European journal of health economics  |d Berlin : Springer, 2001  |g 23(2022), 8 vom: Nov., Seite 1287-1296  |h Online-Ressource  |w (DE-627)320494462  |w (DE-600)2011428-X  |w (DE-576)09670425X  |x 1618-7601  |7 nnas  |a Value drivers of development stage biopharma companies 
773 1 8 |g volume:23  |g year:2022  |g number:8  |g month:11  |g pages:1287-1296  |g extent:10  |a Value drivers of development stage biopharma companies 
856 4 0 |u https://link.springer.com/content/pdf/10.1007/s10198-021-01427-5.pdf  |x Verlag  |z kostenfrei 
856 4 0 |u https://doi.org/10.1007/s10198-021-01427-5  |x Resolving-System  |z kostenfrei 
951 |a AR 
992 |a 20230125 
993 |a Article 
994 |a 2022 
998 |g 1277182337  |a Michaeli, Christoph T.  |m 1277182337:Michaeli, Christoph T.  |d 60000  |d 61400  |e 60000PM1277182337  |e 61400PM1277182337  |k 0/60000/  |k 1/60000/61400/  |p 4  |y j 
998 |g 1277183244  |a Michaeli, Daniel  |m 1277183244:Michaeli, Daniel  |d 60000  |e 60000PM1277183244  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1819636267  |e 4251374584 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Michaeli","given":"Daniel","display":"Michaeli, Daniel","role":"aut"},{"role":"aut","display":"Yagmur, Hasan Basri","given":"Hasan Basri","family":"Yagmur"},{"role":"aut","given":"Timur","family":"Achmadeev","display":"Achmadeev, Timur"},{"display":"Michaeli, Christoph T.","family":"Michaeli","given":"Christoph T.","role":"aut"}],"recId":"1819636267","id":{"doi":["10.1007/s10198-021-01427-5"],"eki":["1819636267"]},"title":[{"title":"Value drivers of development stage biopharma companies","title_sort":"Value drivers of development stage biopharma companies"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg"}],"title":[{"title":"The European journal of health economics","title_sort":"European journal of health economics"}],"pubHistory":["2.2001 -"],"note":["Gesehen am 10.11.23"],"recId":"320494462","id":{"issn":["1618-7601"],"zdb":["2011428-X"],"eki":["320494462"]},"language":["eng"],"disp":"Value drivers of development stage biopharma companiesThe European journal of health economics","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"23(2022), 8 vom: Nov., Seite 1287-1296","year":"2022","issue":"8","extent":"10","volume":"23","pages":"1287-1296"},"titleAlt":[{"title":"Eur J Health Econ"},{"title":"HEPAC"}]}],"name":{"displayForm":["Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, Thomas Michaeli"]},"origin":[{"dateIssuedDisp":"17 January 2022","dateIssuedKey":"2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"language":["eng"]} 
SRT |a MICHAELIDAVALUEDRIVE1720